These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2281404)

  • 1. [The pharmacological committee yesterday, today and tomorrow].
    Lepakhin VK
    Ter Arkh; 1990; 62(9):4-7. PubMed ID: 2281404
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug committees towards the regions. The Danish Society of Clinical Pharmacology].
    Reuther LØ; Brock B;
    Ugeskr Laeger; 2007 Mar; 169(12):1113. PubMed ID: 17394824
    [No Abstract]   [Full Text] [Related]  

  • 3. Opening address at the 1st Congress of the European Association for Clinical Pharmacology and Therapeutics.
    Sjöqvist F
    Therapie; 1996; 51(4):337-40. PubMed ID: 8953802
    [No Abstract]   [Full Text] [Related]  

  • 4. Global challenges for clinical pharmacology in the developing world.
    Blaschke TF
    Clin Pharmacol Ther; 2009 Jun; 85(6):579-81. PubMed ID: 19451910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving role of the P&T committee: enhancing the health technology assessment process.
    Tadlock C
    Manag Care Interface; 2006 Feb; 19(2):14-5. PubMed ID: 16529077
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic advisory program: an opportunity for clinical pharmacology.
    Branch RA; Johnston P
    Clin Pharmacol Ther; 1988 Mar; 43(3):223-7. PubMed ID: 3345613
    [No Abstract]   [Full Text] [Related]  

  • 7. [Research in the field of clinical pharmacology in the USSR].
    Lakin KM; Makarov VA; Novikova NV
    Farmakol Toksikol; 1982; 45(3):5-12. PubMed ID: 7047211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASHP statement on the pharmacy and therapeutics committee.
    Am J Hosp Pharm; 1978 Jul; 35(7):813-4. PubMed ID: 665701
    [No Abstract]   [Full Text] [Related]  

  • 9. [Monitoring of clinical trials and interim analysis. 1. Monitoring committee].
    Boutitie F; Bellissant E; Blanchard J; Boissel JP; Cauquil J; Chauvin F; Derzko G; Ducruet T; Durrleman S; Girre JP
    Therapie; 1992; 47(4):345-9. PubMed ID: 1494799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASHP statement on the pharmacy and therapeutics committee.
    Am J Hosp Pharm; 1992 Aug; 49(8):2008-9. PubMed ID: 1442847
    [No Abstract]   [Full Text] [Related]  

  • 11. The need to improve hospital investigational drug policies and procedures.
    Stolar MH
    Hosp Formul; 1983 Jan; 18(1):79-82. PubMed ID: 10258324
    [No Abstract]   [Full Text] [Related]  

  • 12. [For what purposes is clinical pharmacology needed?].
    Neuvonen PJ; Ylitalo P
    Duodecim; 1998; 114(10):941, 943. PubMed ID: 11524781
    [No Abstract]   [Full Text] [Related]  

  • 13. [The GCP-unit at the Aaarhus University Hospital].
    Jørgensen A; Fabricius S; Nexø E; Djurhuus JC; Rosenberg R; Hammer U; Christiansen JS
    Ugeskr Laeger; 2000 Aug; 162(32):4288-90. PubMed ID: 10962954
    [No Abstract]   [Full Text] [Related]  

  • 14. From clinical trials to usual practice: efficacy and effectiveness in clinical pharmacology.
    Laporte JR
    Methods Find Exp Clin Pharmacol; 1999; 21 Suppl B():17. PubMed ID: 10599039
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of a drug and therapeutics committee in primary health care. Experiences from the 16/Furuset District, Oslo].
    Gorlén T; Juvkam E; Westly T
    Tidsskr Nor Laegeforen; 1991 Jun; 111(16):1995-6. PubMed ID: 1866738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The investigational drug steering committee.
    Ratain MJ
    Clin Adv Hematol Oncol; 2007 Oct; 5(10):779-80. PubMed ID: 17998895
    [No Abstract]   [Full Text] [Related]  

  • 17. [Social aspects of modern pharmacology].
    Zakusov VV
    Farmakol Toksikol; 1983; 46(3):5-12. PubMed ID: 6345191
    [No Abstract]   [Full Text] [Related]  

  • 18. Should all trials have a data safety and monitoring committee?
    Cairns JA; Hallstrom A; Held P
    Am Heart J; 2001 Jan; 141(1):156-63. PubMed ID: 11136502
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for a resident representative on a regional conference steering committee.
    Huber MR; Bookstaver PB; Darling C; Walker MC; Gregory DF
    Am J Health Syst Pharm; 2013 Sep; 70(17):1478-9. PubMed ID: 23943177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.